May 13 |
Akero Therapeutics Inc (AKRO) Q1 2024 Earnings: Misses Analyst Forecast Amid Continued ...
|
May 10 |
Akero Therapeutics GAAP EPS of -$0.90 beats by $0.05
|
May 10 |
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 8 |
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
|
Apr 30 |
Akero Therapeutics names Scott Gangloff as CTO
|
Apr 30 |
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
|
Apr 3 |
Akero Therapeutics' EFX Data Warrants Caution
|
Mar 20 |
Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks
|
Mar 18 |
Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
|
Mar 15 |
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
|